0001104659-22-057539.txt : 20220509 0001104659-22-057539.hdr.sgml : 20220509 20220509161819 ACCESSION NUMBER: 0001104659-22-057539 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220506 FILED AS OF DATE: 20220509 DATE AS OF CHANGE: 20220509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maltz Elliot CENTRAL INDEX KEY: 0001640888 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39362 FILM NUMBER: 22905232 MAIL ADDRESS: STREET 1: C/O GELESIS, INC. STREET 2: 501 BOYLSTON ST., SUITE 6102 CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GELESIS HOLDINGS, INC. CENTRAL INDEX KEY: 0001805087 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 844730610 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 BOYLSTON STREET, SUITE 6102 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-327-7737 MAIL ADDRESS: STREET 1: 501 BOYLSTON STREET, SUITE 6102 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. DATE OF NAME CHANGE: 20200227 4 1 tm2214815d9_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-05-06 0 0001805087 GELESIS HOLDINGS, INC. GLS 0001640888 Maltz Elliot GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 0 1 0 0 Chief Financial Officer Common Stock 2022-05-06 4 A 0 5082 A 5082 D Common Stock 2022-05-06 4 A 0 31392 A 36474 D Common Stock 2022-05-06 4 A 0 395501 A 431975 D Stock Option (Right to Buy) 3.33 2022-05-06 4 A 0 395501 0 A 2032-03-03 Common Stock 395501 395501 D Represents a grant of restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement. These RSUs vest in full on February 6, 2023, subject to the reporting person's continued service at such time. These RSUs vest in full on February 12, 2023, subject to the reporting person's continued service at such time. 25% of these RSUs shall vest on April 1, 2023, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date. 25% of the shares underlying this option shall vest and become exercisable on March 4, 2023, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date. /s/ David Abraham, Attorney-in-Fact 2022-05-09